$IMDX Q2 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. reported Q2 2026 revenue of approximately $239,000 with a gross profit of $157,000, representing a 65.7% gross margin, while the net loss reached $11.3 million for the quarter.
$IMDX Q2 '26 Earnings Results & Recap Insight Molecular Diagnostics Inc. reported Q2 2026 revenue of approximately $239,000 with a gross profit of $157,000, representing a 65.7% gross margin, while the net loss reached $11.3 million for the quarter.